Can-Fite BioPharma Ltd. is an advanced clinical-stage biopharmaceutical company incorporated in 1994 in Israel, developing orally bioavailable small molecule therapeutics for cancer, liver, and inflammatory diseases. Its pipeline is based on the A3 adenosine receptor (A3AR) platform and includes three product candidates: Piclidenoson (CF101), Namodenoson (CF102), and CF602. The company has not commercialized any products and finances operations through equity sales and out-licensing agreements.
Look up CANF using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on CANF, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/CANF (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.